basiliximab
Showing 1 - 25 of 61
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Liver Transplantation Trial in Los Angeles (Basiliximab, Tacrolimus, Mycophenolic Acid)
Completed
- Liver Transplantation
- Basiliximab
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Sep 14, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Thymoglobulin Versus Basiliximab on Regulatory T Cell Function
Suspended
- KIDNEY TRANSPLANTATION
- Basiliximab
- Thymoglobulin
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 30, 2021
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)
Recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Basiliximab
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 16, 2022
Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)
Recruiting
- Safety and Efficacy
- Basiliximab
- Vedolizumab
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Sep 27, 2023
Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)
Completed
- Malignant Neoplasms Brain
- RNA-loaded dendritic cell vaccine
- basiliximab
-
Durham, North CarolinaDuke University Medical Center
Mar 8, 2021
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)
Active, not recruiting
- Kidney Transplant
- Type 1 Diabetes
- Alpha 1-Antitrypsin
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Kidney Transplant Trial in Suwan (Mycophenolate mofetil 500mg Tab. or 250mg Cap., Tacrolimus, Methylprednisolone/prednisolone)
Active, not recruiting
- Kidney Transplant
- Mycophenolate mofetil 500mg Tab. or 250mg Cap.
- +3 more
-
Suwan, Korea, Republic ofAjou University Hospital
Jul 6, 2021
Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)
Unknown status
- Extranodal NK/T-cell Lymphoma
- Basiliximab
- Pegaspargase
- (no location specified)
Apr 6, 2020
Primary Renal Allograft Candidate, Kidney Transplantation Trial in Birmingham, San Francisco, Atlanta (Anti-thymocyte Globulin
Terminated
- Primary Renal Allograft Candidate
- Kidney Transplantation
- Anti-thymocyte Globulin (Rabbit)
- +5 more
-
Birmingham, Alabama
- +2 more
Nov 24, 2020
Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Veracruz (Basiliximab, Thymoglobulin)
Completed
- Kidney Transplant Rejection
- Kidney Transplant; Complications
- Basiliximab
- Thymoglobulin
-
Veracruz, MexicoUmae Hospital Especialidades 14 Adolfo Ruiz Cortines
Nov 14, 2019
Kidney Transplantation Trial in United Kingdom (Alemtuzumab, Basiliximab, Sirolimus)
Completed
- Kidney Transplantation
- Alemtuzumab
- +3 more
-
Oxford, Oxon, United Kingdom
- +19 more
Mar 23, 2020
Thalassemia Major Trial in Nanning (Busulfan, Cyclophosphamide, Fludarabine)
Recruiting
- Thalassemia Major
- Busulfan
- +9 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Jul 3, 2019
Type 1 Diabetes Trial in Canada, United States (biological, drug, procedure)
Completed
- Type 1 Diabetes Mellitus
- Allogeneic Pancreatic Islet Cells
- +6 more
-
San Francisco, California
- +7 more
Jul 11, 2019
Lung; Disease, Interstitial, With Fibrosis, Dermatomyositis Trial in Shanghai (Basiliximab, Calcineurin Inhibitors, Steroids)
Unknown status
- Lung; Disease, Interstitial, With Fibrosis
- Dermatomyositis
- Basiliximab
- +2 more
-
Shanghai, Shanghai, ChinaRenJi Hospital
Jun 18, 2017
Amyotrophic Lateral Sclerosis (ALS) Trial in Atlanta, Boston, Worcester (Basiliximab, Methylprednisolone, Prednisone)
Completed
- Amyotrophic Lateral Sclerosis (ALS)
- Basiliximab
- +4 more
-
Atlanta, Georgia
- +2 more
Nov 2, 2017
Kidney Transplantation, Adverse Effects Trial in Basel (basiliximab, MMF/EC-MPS, Corticosteroids)
Completed
- Kidney Transplantation
- Adverse Effects
- basiliximab
- +2 more
-
Basel, SwitzerlandNovartis
Mar 27, 2017
Kidney Transplantation, Renal Transplantation Trial in Birmingham, San Francisco, Atlanta (Alemtuzumab, MMF, Basiliximab)
Terminated
- Kidney Transplantation
- Renal Transplantation
- Alemtuzumab
- +6 more
-
Birmingham, Alabama
- +2 more
Aug 29, 2017
Kidney Transplantation Trial (basiliximab, efalizumab, mycophenolate mofetil)
Withdrawn
- Kidney Transplantation
- basiliximab
- +4 more
- (no location specified)
Jun 21, 2017
Thalassemia Major Trial in Nanning (Busulfan, Cyclophosphamide, Fludarabine)
Unknown status
- Thalassemia Major
- Busulfan
- +7 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
May 27, 2017